0102030405
CAS 141732-76-5 Exenatide Acetate China umenzi wokuthengisa ngokuthe ngqo ixabiso elifanelekileyo loKhuseleko oluPhezulu loKhuseleko loKhuseleko olugqwesileyo Umgangatho ophezulu weendleko zokwaneliseka Ukuhanjiswa ngokukhawuleza
Ingcaciso yeMveliso
Ukusetyenziswa kwe-exenatide kubangela ukwanda kwe-acinar cAMP ngaphandle kokuvuselela ukukhutshwa kwe-amylase. Njenge-incretin mimetic, i-exenatide isebenza njenge-agonist ye-glucagon-like peptide-1 (GLP-1) receptor. Njenge-GLP-1, nangona inomsebenzi omde, i-exenatide yongeza imveliso yasemva kokutya kwe-insulin kwaye icinezela ukukhutshwa kweglucagon. Ngenxa yesi sizathu, i-exenatide ifumene ukusetyenziswa njengeyeza le-diabetes II.
ividiyo yemveliso
Isicelo seMveliso
Ukusetyenziswa kwe-acetate ye-exenatide kubangela ukwanda kwe-acinar cAMP ngaphandle kokuvuselela ukukhululwa kwe-amylase. Njenge-incretin mimetic, i-exenatide acetate isebenza njenge-agonist ye-glucagon-like peptide-1 (GLP-1) receptor. Njenge-GLP-1, nangona inomsebenzi omde, i-exenatide acetate yongeza imveliso ye-insulin yangemva kokutya kwaye icinezela ukukhuselwa kweglucagon. Ngenxa yesi sizathu, i-exenatide acetate ifumene ukusetyenziswa njengeyeza le-diabetes II.
ukucaciswa kwemveliso
| Igama eliqhelekileyo | Exenatide Acetate |
| Inombolo yeCAS | 141732-76-5 |
| Ifomula yeemolekyuli | I-C186H286N50O62S |
| Ubunzima beMolekyuli | 4246.62000 |
PSA | 1812.35000 |
EINECS | 1592732-453-0 |
Iphakheji
Ukuhambisa ngenqanawe
FAQ
ulwazi lwenkampani
umzi-mveliso kunye neWarehouse
Inzuzo Yethu
